Results 161 to 170 of about 1,463,832 (396)
Geographic and Socioeconomic Landscape of Veterans With Head and Neck Cancer
ABSTRACT Background US Veterans experience higher rates and worse outcomes for head and neck squamous cell carcinoma (HNSCC) compared to civilians. Geographic and socioeconomic barriers remain unclear. Methods This retrospective descriptive study analyzed VA data nationwide (2012–2022), identifying Veterans with HNSCC using ICD codes. Subsites included
Kristen L. Zayan+8 more
wiley +1 more source
BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma [PDF]
published_or_final_versio
Chan, YW+5 more
core +1 more source
ABSTRACT Background Head and neck cancers (HNCs) are too often diagnosed at advanced stages when outcomes are poor. Additionally, robust tools for the early detection of recurrence remain elusive. These gaps drive interest in so‐called liquid biopsy approaches for HNC detection, prognostication, and surveillance.
Patricia J. Brooks, Scott V. Bratman
wiley +1 more source
Nasopharyngeal carcinoma in greece is associated with elevated levels of EBV-specific antibodies and EBV DNA [PDF]
S. I. Koliais+5 more
openalex +1 more source
Epithelial cell adhesion molecule (EpCAM) is known to be highly expressed in a variety of epithelial carcinomas, and it is involved in cell adhesion and proliferation.
Meng-He Wang+11 more
semanticscholar +1 more source
What's New? Poor prognosis in cholangiocarcinoma (CCA) is attributed to late diagnosis and intrinsic chemoresistance. In particular, resistance mechanisms that suppress apoptosis limit the effectiveness of gemcitabine‐based regimens, which remain the standard treatment.
Wunan Mi+7 more
wiley +1 more source
Factors affecting serum IgA antibody to Epstein-Barr viral capsid antigens in nasopharyngeal carcinoma [PDF]
Hsing-Ying Ho, Mun Hon Ng, H. C. Kwan
openalex +1 more source
Recent advances in the management of nasopharyngeal carcinoma
Over the last few years, certain areas in the management nasopharyngeal carcinoma (NPC) that have an impact on the care of these patients have evolved, particularly with regard to liquid biopsies, minimally invasive surgery, and advances in chemotherapy ...
W. K. Jacky Lam, Jason Y. K. Chan
semanticscholar +1 more source
What's New? While artificial intelligence (AI) can potentially support clinical decision‐making in recurrent head and neck squamous cell carcinoma (HNSCC), its reliability and accuracy require extensive investigation. Here, the performance of ChatGPT‐4 as a decision‐support tool for staging and treatment planning in HNSCC was assessed. The tool was 83%
Danfang Yan+9 more
wiley +1 more source
Book Review: Nasopharyngeal Carcinoma: Etiology and Control [PDF]
H. J. Shaw
openalex +1 more source